Literature DB >> 28281308

Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi.

Vanessa D Smith1, Adam D Bachstetter2,3, Eseosa Ighodaro3,4, Kelly Roberts2, Erin L Abner4,5, David W Fardo6, Peter T Nelson1,3,4.   

Abstract

Intracellular proteinaceous aggregates (inclusion bodies) are almost always detectable at autopsy in brains of elderly individuals. Inclusion bodies composed of TDP-43 and tau proteins often coexist in the same brain, and each of these pathologic biomarkers is associated independently with cognitive impairment. However, uncertainties remain about how the presence and neuroanatomical distribution of inclusion bodies correlate with underlying diseases including Alzheimer's disease (AD). To address this knowledge gap, we analyzed data from the University of Kentucky AD Center autopsy series (n = 247); none of the brains had frontotemporal lobar degeneration. A specific question for this study was whether neurofibrillary tangle (NFT) pathology outside of the Braak NFT staging scheme is characteristic of brains with TDP-43 pathology but lacking AD, that is those with cerebral age-related TDP-43 with sclerosis (CARTS). We also tested whether TDP-43 pathology is associated with comorbid AD pathology, and whether argyrophilic grains are relatively likely to be present in cases with, vs. without, TDP-43 pathology. Consistent with prior studies, hippocampal TDP-43 pathology was associated with advanced AD - Braak NFT stages V/VI. However, argyrophilic grain pathology was not more common in cases with TDP-43 pathology in this data set. In brains with CARTS (TDP-43[+]/AD[-] cases), there were more NFTs in dentate granule neurons than were seen in TDP-43[-]/AD[-] cases. These dentate granule cell NFTs could provide a proxy indicator of CARTS pathology in cases lacking substantial AD pathology. Immunofluorescent experiments in a subsample of cases found that, in both advanced AD and CARTS, approximately 1% of dentate granule neurons were PHF-1 immunopositive, whereas ∼25% of TDP-43 positive cells showed colocalized PHF-1 immunoreactivity. We conclude that NFTs in hippocampal dentate granule neurons are often present in CARTS, and TDP-43 pathology may be secondary to or occurring in parallel with tauopathy.
© 2017 International Society of Neuropathology.

Entities:  

Keywords:  FTLD; HS-aging; colocalization; hippocampal sclerosis; hippocampus; oldest-old

Mesh:

Substances:

Year:  2017        PMID: 28281308      PMCID: PMC5591757          DOI: 10.1111/bpa.12505

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  83 in total

1.  TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy.

Authors:  Ann C McKee; Brandon E Gavett; Robert A Stern; Christopher J Nowinski; Robert C Cantu; Neil W Kowall; Daniel P Perl; E Tessa Hedley-Whyte; Bruce Price; Chris Sullivan; Peter Morin; Hyo-Soon Lee; Caroline A Kubilus; Daniel H Daneshvar; Megan Wulff; Andrew E Budson
Journal:  J Neuropathol Exp Neurol       Date:  2010-09       Impact factor: 3.685

2.  Co-localization of tau and alpha-synuclein in the olfactory bulb in Alzheimer's disease with amygdala Lewy bodies.

Authors:  Hiroshige Fujishiro; Yoshio Tsuboi; Wen-Lang Lin; Hirotake Uchikado; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2008-04-30       Impact factor: 17.088

3.  Estimating the number of persons with frontotemporal lobar degeneration in the US population.

Authors:  David S Knopman; Rosebud O Roberts
Journal:  J Mol Neurosci       Date:  2011-05-17       Impact factor: 3.444

4.  Neuropathologic correlates of regional brain volumes in a community cohort of older adults.

Authors:  Aikaterini Kotrotsou; Julie A Schneider; David A Bennett; Sue E Leurgans; Robert J Dawe; Patricia A Boyle; Tom Golak; Konstantinos Arfanakis
Journal:  Neurobiol Aging       Date:  2015-06-30       Impact factor: 4.673

5.  Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both.

Authors:  M L Kraybill; E B Larson; D W Tsuang; L Teri; W C McCormick; J D Bowen; W A Kukull; J B Leverenz; M M Cherrier
Journal:  Neurology       Date:  2005-06-28       Impact factor: 9.910

6.  Molecular analysis and biochemical classification of TDP-43 proteinopathy.

Authors:  Hiroshi Tsuji; Tetsuaki Arai; Fuyuki Kametani; Takashi Nonaka; Makiko Yamashita; Masami Suzukake; Masato Hosokawa; Mari Yoshida; Hiroyuki Hatsuta; Masaki Takao; Yuko Saito; Shigeo Murayama; Haruhiko Akiyama; Masato Hasegawa; David M A Mann; Akira Tamaoka
Journal:  Brain       Date:  2012-10-03       Impact factor: 13.501

7.  Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study.

Authors:  Kathryn P Riley; David A Snowdon; William R Markesbery
Journal:  Ann Neurol       Date:  2002-05       Impact factor: 10.422

8.  Clinical and neuropathological characteristics of hippocampal sclerosis: a community-based study.

Authors:  James B Leverenz; Christina M Agustin; Debby Tsuang; Elaine R Peskind; Steven D Edland; David Nochlin; Lillian DiGiacomo; James D Bowen; Wayne C McCormick; Linda Teri; Murray A Raskind; Walter A Kukull; Eric B Larson
Journal:  Arch Neurol       Date:  2002-07

9.  Accumulation of phosphorylated TDP-43 in brains of patients with argyrophilic grain disease.

Authors:  Hiroshige Fujishiro; Hirotake Uchikado; Tetsuaki Arai; Masato Hasegawa; Haruhiko Akiyama; Osamu Yokota; Kuniaki Tsuchiya; Takashi Togo; Eizo Iseki; Yoshio Hirayasu
Journal:  Acta Neuropathol       Date:  2008-11-28       Impact factor: 17.088

10.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.

Authors:  Heiko Braak; Irina Alafuzoff; Thomas Arzberger; Hans Kretzschmar; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2006-08-12       Impact factor: 17.088

View more
  34 in total

1.  Detergent Insoluble Proteins and Inclusion Body-Like Structures Immunoreactive for PRKDC/DNA-PK/DNA-PKcs, FTL, NNT, and AIFM1 in the Amygdala of Cognitively Impaired Elderly Persons.

Authors:  Jozsef Gal; Jing Chen; Yuriko Katsumata; David W Fardo; Wang-Xia Wang; Sergey Artiushin; Douglas Price; Sonya Anderson; Ela Patel; Haining Zhu; Peter T Nelson
Journal:  J Neuropathol Exp Neurol       Date:  2018-01-01       Impact factor: 3.685

2.  Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy (PART) and Alzheimer's disease.

Authors:  W Robert Bell; Yang An; Yusuke Kageyama; Collin English; Gay L Rudow; Olga Pletnikova; Madhav Thambisetty; Richard O'Brien; Abhay R Moghekar; Marilyn S Albert; Peter V Rabins; Susan M Resnick; Juan C Troncoso
Journal:  Alzheimers Dement       Date:  2018-12-11       Impact factor: 21.566

3.  Novel monoclonal antibodies targeting the RRM2 domain of human TDP-43 protein.

Authors:  Jorge A Trejo-Lopez; Zachary A Sorrentino; Cara J Riffe; Grace M Lloyd; Sydney A Labuzan; Dennis W Dickson; Anthony T Yachnis; Stefan Prokop; Benoit I Giasson
Journal:  Neurosci Lett       Date:  2020-09-06       Impact factor: 3.046

Review 4.  The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases.

Authors:  Peter T Nelson; Erin L Abner; Ela Patel; Sonya Anderson; Donna M Wilcock; Richard J Kryscio; Linda J Van Eldik; Gregory A Jicha; Zsombor Gal; Ruth S Nelson; Bela G Nelson; Jozsef Gal; Md Tofial Azam; David W Fardo; Matthew D Cykowski
Journal:  J Neuropathol Exp Neurol       Date:  2018-01-01       Impact factor: 3.685

5.  TDP-43 Neuropathologic Associations in the Nun Study and the Honolulu-Asia Aging Study.

Authors:  Margaret E Flanagan; Brenna Cholerton; Caitlin S Latimer; Laura S Hemmy; Steven D Edland; Kathleen S Montine; Lon R White; Thomas J Montine
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

6.  TDP-43 proteinopathy in aging: Associations with risk-associated gene variants and with brain parenchymal thyroid hormone levels.

Authors:  Peter T Nelson; Zsombor Gal; Wang-Xia Wang; Dana M Niedowicz; Sergey C Artiushin; Samuel Wycoff; Angela Wei; Gregory A Jicha; David W Fardo
Journal:  Neurobiol Dis       Date:  2019-01-23       Impact factor: 5.996

7.  Phosphorylated TDP-43 Staging of Primary Age-Related Tauopathy.

Authors:  Xiaoling Zhang; Bing Sun; Xing Wang; Hui Lu; Fangjie Shao; Annemieke J M Rozemuller; Huazheng Liang; Chong Liu; Jiadong Chen; Manli Huang; Keqing Zhu
Journal:  Neurosci Bull       Date:  2018-10-31       Impact factor: 5.203

8.  Reply: Selected cryptic exons accumulate in hippocampal cell nuclei in Alzheimer's disease with and without associated TDP-43 proteinopathy.

Authors:  Peter T Nelson
Journal:  Brain       Date:  2020-03-01       Impact factor: 13.501

9.  Limbic Predominant Age-Related TDP-43 Encephalopathy (LATE): Clinical and Neuropathological Associations.

Authors:  Lilah M Besser; Merilee A Teylan; Peter T Nelson
Journal:  J Neuropathol Exp Neurol       Date:  2020-03-01       Impact factor: 3.685

10.  Asymmetry of Hippocampal Tau Pathology in Primary Age-Related Tauopathy and Alzheimer Disease.

Authors:  Jamie M Walker; Yelena Fudym; Kurt Farrell; Megan A Iida; Kevin F Bieniek; Sudha Seshadri; Charles L White; John F Crary; Timothy E Richardson
Journal:  J Neuropathol Exp Neurol       Date:  2021-04-16       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.